Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Bassam S. Abdulkarim"'
Autor:
Paul Daniel, Siham Sabri, Ahmad Chaddad, Brian Meehan, Bertrand Jean-Claude, Janusz Rak, Bassam S. Abdulkarim
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Glioma are the most common type of malignant brain tumor, with glioblastoma (GBM) representing the most common and most lethal type of glioma. Surgical resection followed by radiotherapy and chemotherapy using the alkylating agent Temozolomide (TMZ)
Externí odkaz:
https://doaj.org/article/11365748e5fb420c90b63cf3529b6f11
Publikováno v:
Cancers. 14(15)
Cancer patients, specifically lung cancer patients, show heightened vulnerability to severe COVID-19 outcomes. The immunological and inflammatory pathophysiological similarities between lung cancer and COVID-19-related ARDS might explain the predispo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78d1912a466ab5a63a54b1589709fc5e
https://pubmed.ncbi.nlm.nih.gov/35892857
https://pubmed.ncbi.nlm.nih.gov/35892857
Publikováno v:
Cancer Research. 70:3740-3740
Background/Purpose: Acute skin toxicity is a common side effect of radiation therapy (RT) in breast-cancer patients. We hypothesized that RT modulates the levels of circulating endothelial cells with a progenitor-like phenotype (EPCs) and/or circulat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8657720ad603895cb4f3c0645eb74885
https://doi.org/10.1158/1538-7445.am10-3740
https://doi.org/10.1158/1538-7445.am10-3740
Autor:
Konrad S. Famulski, Bassam S. Abdulkarim, Yaoxian Xu, David Murray, Siham Sabri, Manik Chahal
Publikováno v:
Cancer Research. 70:1290-1290
Background: Glioblastoma (GBM) is the most aggressive primary malignant brain tumor in adults. Approximately 50% of GBM patients are resistant to standard therapy with temozolomide (TMZ) because their tumors express the DNA repair protein O6-methylgu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d239fe3892657fc531cd4110ed998068
https://doi.org/10.1158/1538-7445.am10-1290
https://doi.org/10.1158/1538-7445.am10-1290
Publikováno v:
Cancer Research. 69:2014
Abstract #2014 Problem Statement: Radiation therapy followed by Trastuzumab-based therapy is the standard of care for Her-2 positive breast cancer (BC) patients, but the molecular basis of this sequential treatment has not been investigated. Fifty pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d22747cabe961a9494ba2893dfc00f88
https://doi.org/10.1158/0008-5472.sabcs-2014
https://doi.org/10.1158/0008-5472.sabcs-2014